Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Optometry
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2025 / June / PPV Glaucoma Risk
Glaucoma Retina

PPV Glaucoma Risk

Study observes risk of pars plana vitrectomy patients developing glaucoma within five years of procedure

By Alun Evans 6/11/2025 3 min read

Share

0625-205 PPV Glaucoma Risk.png

Credit:Adobestock.com

A common and effective procedure in the modern era, pars plana vitrectomy (PPV) and its early post-operative effects of elevated intraocular pressure (IOP) have been well documented. Similarly, optic nerve damage caused by raised IOP has also been noted as a potential side-effect of the surgery even years after it has first been performed. But what still remains unclear is how much risk of developing glaucoma patients might be facing when undergoing PPV.

To more accurately determine the long-term vision risks PPV patients might encounter, researchers from the Byers Eye Institute of Stanford University, Palo Alto, CA, have conducted a retrospective cohort study of 42,242 PPV patients.

“There have been numerous smaller studies highlighting a possible increased risk of glaucoma in vitrectomized eyes, but not all studies have yielded the same results,” explains Jonathan Lin, corresponding study author and vitreoretinal surgery fellow at the Byers Eye Institute. “We sought to leverage a large, federated electronic health record network to address this gap of knowledge.”

The data was taken from the TriNetX Health Research Network in Cambridge, MA, a large anonymized electronic health records network featuring information from 67 large US healthcare institutions and comprising clinical data on more than 250 million patients worldwide.

Lin and his team reported that 5.4 percent of the 42,242 PPV patients – all with no prior history of glaucoma – were diagnosed with the condition between three months and five years after the procedure.

“Our findings highlight the need for patients who undergo PPV to be monitored for ocular hypertension and glaucoma, since this can lead to progressive, permanent vision loss if it is not treated adequately,” Lin says.

A further “intriguing finding,” he adds, was that “the risk of glaucoma in vitrectomized eyes was higher in patients who had undergone PPV after a diagnosis of retinal detachment compared to those who had undergone PPV after a diagnosis of either epiretinal membrane or macular hole.” This indicates that surgical factors of the procedure could also play a part in the risk of PPV patients later developing glaucoma, a finding that Lin states “warrants further investigation.”

About the Author(s)

Alun Evans

More Articles by Alun Evans

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: